EP1234030A4 - 18 HUMAN SECRETED PROTEINS - Google Patents

18 HUMAN SECRETED PROTEINS

Info

Publication number
EP1234030A4
EP1234030A4 EP00978592A EP00978592A EP1234030A4 EP 1234030 A4 EP1234030 A4 EP 1234030A4 EP 00978592 A EP00978592 A EP 00978592A EP 00978592 A EP00978592 A EP 00978592A EP 1234030 A4 EP1234030 A4 EP 1234030A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00978592A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1234030A2 (en
Inventor
Steven M Ruben
George A Komatsoulis
Kevin P Baker
Paul E Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1234030A2 publication Critical patent/EP1234030A2/en
Publication of EP1234030A4 publication Critical patent/EP1234030A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP00978592A 1999-11-19 2000-11-15 18 HUMAN SECRETED PROTEINS Withdrawn EP1234030A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16641599P 1999-11-19 1999-11-19
US166415P 1999-11-19
US21513600P 2000-06-30 2000-06-30
US215136P 2000-06-30
PCT/US2000/031162 WO2001036432A2 (en) 1999-11-19 2000-11-15 18 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1234030A2 EP1234030A2 (en) 2002-08-28
EP1234030A4 true EP1234030A4 (en) 2003-05-07

Family

ID=26862246

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00978592A Withdrawn EP1234030A4 (en) 1999-11-19 2000-11-15 18 HUMAN SECRETED PROTEINS

Country Status (5)

Country Link
EP (1) EP1234030A4 (ja)
JP (1) JP2003514541A (ja)
AU (1) AU1604401A (ja)
CA (1) CA2388777A1 (ja)
WO (1) WO2001036432A2 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192589B2 (en) * 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US7625756B2 (en) 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
EP2322644A1 (en) 2000-06-28 2011-05-18 GlycoFi, Inc. Methods for producing modified glycoproteins
US7598055B2 (en) 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
MXPA03001645A (es) * 2000-08-24 2004-05-14 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
US20040152105A1 (en) * 2002-09-06 2004-08-05 Cytos Biotechnology Ag. Immune modulatory compounds and methods
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
AU2006311803C1 (en) 2005-11-04 2015-05-14 Genentech, Inc. Use of complement pathway inhibitors to treat ocular diseases
US7776573B2 (en) 2006-06-01 2010-08-17 Genentech, Inc. Crystal structure of CRIg and C3b:CRIg complex
TWI391401B (zh) 2006-11-02 2013-04-01 Genentech Inc 人類化之抗-因子ｄ抗體及其用途
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
AR071635A1 (es) 2008-05-06 2010-06-30 Genentech Inc Variantes de crig (receptor asociado a macrofagos) que tienen afinidad de union aumentada a c3b, con union selectiva sobre c3 (ambas proteinas del complemento).
KR101137019B1 (ko) 2009-05-25 2012-05-24 한국생명공학연구원 신규한 ｇｐｃｒ 단백질 및 이의 용도
CA2795789A1 (en) 2010-04-09 2011-10-13 Amgen Inc. Btnl9 proteins, nucleic acids, and antibodies and uses thereof
KR20160042438A (ko) 2013-08-12 2016-04-19 제넨테크, 인크. 보체-연관 상태의 치료를 위한 조성물 및 방법
PE20161440A1 (es) 2014-05-01 2017-01-26 Genentech Inc Variantes del anticuerpo anti-factor d y sus usos
WO2017075173A2 (en) 2015-10-30 2017-05-04 Genentech, Inc. Anti-factor d antibodies and conjugates
WO2017075252A1 (en) 2015-10-30 2017-05-04 Genentech, Inc. Anti-factor d antibody variant conjugates and uses thereof
JP7076076B2 (ja) * 2016-03-03 2022-05-27 東亞合成株式会社 シグナルペプチドを指標にした筋萎縮性側索硬化症の診断方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023546A1 (en) * 1999-09-27 2001-04-05 Human Genome Sciences, Inc. 37 human secreted proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001550A1 (en) * 1997-07-03 1999-01-14 Dana-Farber Cancer Institute A method for detection of alterations in msh5
JPH11313673A (ja) * 1998-04-30 1999-11-16 Hoechst Marion Roussel Kk ヒトｂｍｐ−２プロモーターおよびこれを用いた骨関連物質の探索法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023546A1 (en) * 1999-09-27 2001-04-05 Human Genome Sciences, Inc. 37 human secreted proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOLL WERNER ET AL: "Messenger RNAs expressed in intestine of adult but not baby rabbits: Isolation of cognate cDNAs and characterization of a novel brush border protein with esterase and phospholipase activity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 268, no. 17, 15 June 1993 (1993-06-15), pages 12901 - 12911, XP002200728, ISSN: 0021-9258 *
DATABASE EMBL [online] 11 October 1999 (1999-10-11), BIRREN ET AL.: "Homo sapiens clone RP11-13H7, WORKING DRAFT SEQUENCE, 7 unordered pieces", XP002220028, Database accession no. AC011640 *
See also references of WO0136432A3 *

Also Published As

Publication number Publication date
AU1604401A (en) 2001-05-30
WO2001036432A3 (en) 2002-05-10
JP2003514541A (ja) 2003-04-22
EP1234030A2 (en) 2002-08-28
CA2388777A1 (en) 2001-05-25
WO2001036432A2 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
EP1218408A4 (en) 32 HUMAN, SECRETED PROTEINS
EP1212343A4 (en) 52 HUMAN SECRETED PROTEINS
EP1181390A4 (en) 27 HUMAN SECRETED PROTEINS
EP1224285A4 (en) 27 HUMAN SECRETED PROTEINS
EP1234030A4 (en) 18 HUMAN SECRETED PROTEINS
EP1212342A4 (en) 18 HUMAN-SECRETED PROTEINS
EP1226231A4 (en) 19 HUMAN SECRETED PROTEINS
EP1175438A4 (en) 62 HUMANE SECRETIED PROTEINS
EP1192278A4 (en) 48 HUMAN SECRETED PROTEINS
EP1192176A4 (en) 49 HUMAN SECRETED PROTEINS
EP1165827A4 (en) 45 HUMAN SECRETED PROTEINS
EP1175439A4 (en) 49 HUMANE SECRETIED PROTEINS
EP1159284A4 (en) 33 HUMAN SECRETARY PROTEINS
EP1189917A4 (en) 48 HUMAN SECRETED PROTEINS
EP1185543A4 (en) 50 HUMAN-SECRETED PROTEINS
EP1173477A4 (en) 49 HUMAN SECRETED PROTEINS
EP1224201A4 (en) 32 HUMAN SECRETED PROTEINS
EP1203005A4 (en) 25 HUMAN SECRETED PROTEINS
EP1206573A4 (en) 26 HUMAN SECRETED PROTEINS
EP1165602A4 (en) 49 PROTEINS SECRETED BY A HUMAN BEING
EP1144614A4 (en) HUMAN, ELIMINATED PROTEINS
EP1169332A4 (en) 49 HUMAN SECRETED PROTEINS
EP1171460A4 (en) 48 HUMAN SECRETED PROTEINS
EP1165828A4 (en) 50 HUMAN SECRETED PROTEINS
EP1185285A4 (en) 49 HUMAN SECRETED PROTEINS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020619

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HUMAN GENOME SCIENCES, INC.

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/11 A, 7C 12Q 1/68 B, 7C 12N 15/00 B, 7C 07K 14/47 B

A4 Supplementary search report drawn up and despatched

Effective date: 20030321

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061026